First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

BACKGROUND: Chemotherapy based on platinum is the standard treatment for unresectable malignant pleural mesothelioma (MPM). Liposomal doxorubicin (LD) consists of pegylated phospholipid vesicles that encapsulate doxorubicin-enhancing liposome deposition in the tumour. We evaluated the toxicity profi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Arrieta, Ó, Medina, L A, Estrada-Lobato, E, Hernández-Pedro, N, Villanueva-Rodríguez, G, Martínez-Barrera, L, Macedo, E O, López-Rodríguez, V, Motola-Kuba, D, Corona-Cruz, J F
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2012
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304415/
https://ncbi.nlm.nih.gov/pubmed/22353806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.44
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky